SABCS 2015: Less Treatment Is More for Early-stage Breast Cancer
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Breast-conserving surgery may be a better option than mastectomy for patients with early-stage breast cancer.
Adding denosumab (Xgeva) to adjuvant aromatase inhibitor therapy improved disease-free survival for postmenopausal women with early-stage hormone receptor-positive breast...
Studies presented at this year’s San Antonio Breast Cancer Symposium shed light on new investigational therapies for patients with...
The AACR’s disparities conference covered a wide array of issues this year, from the biological factors that make some...
Kimberly Stegmaier, MD, co-director of the pediatric hematologic malignancy program and associate professor of pediatrics at Dana-Farber Cancer Institute...
Levi Garraway, MD, PhD, co-chair of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston Nov....
Later today, more than 200 scientists working diligently to advance the field of epigenetics research will convene in Atlanta...
The inaugural International Cancer Immunotherapy Conference, hosted jointly by the Cancer Research Institute (CRI), the Association for Cancer Immunotherapy...
China, a nation of 1.3 billion people, is facing an ongoing cancer epidemic, with more than 3 million people...
Every year, the American Association for Cancer Research (AACR) organizes a robust program of educational workshops for early-career investigators...